Company Information

What does Impax do?

Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Impax Generics division and markets its branded products through the Impax Specialty Pharma division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at:

What year was Impax incorporated in and in what state?

Impax was incorporated in 1995 in the state of Delaware.

When was Impax formed?

Impax Laboratories was formed in December 1999 through the merger of publicly-traded Global Pharmaceuticals and privately-held Impax Pharmaceuticals.

Where are Impax's headquarters?

Impax Laboratories, Inc.
30831 Huntwood Ave.
Hayward, CA 94544
Phone: (510) 240-6000
Fax: (510) 471-3200

Investor Relations and Media Relations Contact:
Mark Donohue
Vice President
Investor Relations and Corporate Communications
(215) 558-4526

Financial Reporting & Stock Information:

What is Impax's fiscal year?

December 31.

Does Impax issue dividends on its common stock?


May I purchase shares directly from the Company?

No. Shares may be purchased through a broker-dealer.

How do I replace lost or stolen stock certificates?

Contact our transfer agent.

External Advisors and Contact Information:

Who is Impax's transfer agent?

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Tel: 866-621-2792
Fax: 718-236-2641

Who are Impax's independent accountants?

1601 Market Street
Philadelphia, PA 19103

How can I get a copy of Impax's annual report?

The annual report and other SEC filings are available here.